BENJAMIN WEISMAN, M.D.
Specialist in BRIDGEPORT, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BENJAMIN WEISMAN, M.D. reported a CMS MIPS final score of 84.4788/100 — above the 83.1 national average — and filed 1,631 Medicare Part D claims in 2023.
- 84.4788/100
- MIPS score · +1 vs avg
- 2K
- Part D claims, 2023
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BENJAMIN WEISMAN, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
84 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about BENJAMIN WEISMAN, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Specialist compares to other specialties among Connecticut providers
Specialist share within Connecticut
Specialist is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
BENJAMIN WEISMAN, M.D.'s 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 84.4788/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) — 84.4788/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Specialist US NPIs
84.4788/100 MIPS final score — 1.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Specialist. Quality dim: 79.2865. Cost dim: 59.5997.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BENJAMIN WEISMAN, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 4699 MAIN ST, BRIDGEPORT, CT, 06606, with a listed phone of (203) 374-2747. NPI 1427053073 was issued on 06/20/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WEISMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,631 prescription claims written by this provider, covering 287 Medicare beneficiaries and totaling roughly $356K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.4788/100 for the 2023 performance year (Quality 79.2865, Cost 59.5997), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1427053073 |
|---|---|
| Specialty | Specialist |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/20/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BENJAMIN WEISMAN, M.D.'s current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,069
- Total Day Supply
- 120,769
- Generic Drug Cost
- $31K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 76.5 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 59% female / 41% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BENJAMIN WEISMAN, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
106 claims
- Montelukast Sodium
Montelukast Sodium
97 claims
- Lisinopril
Lisinopril
80 claims
- Levothyroxine Sodium
Levothyroxine Sodium
79 claims
- Atorvastatin Calcium
Atorvastatin Calcium
73 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
57 claims
- Metoprolol Succinate
Metoprolol Succinate
46 claims
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
44 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 106 |
| Montelukast Sodium | 97 |
| Lisinopril | 80 |
| Levothyroxine Sodium | 79 |
| Atorvastatin Calcium | 73 |
| Rosuvastatin Calcium | 57 |
| Metoprolol Succinate | 46 |
| Levocetirizine Dihydrochloride | 44 |
| Tamsulosin Hcl | 42 |
| Simvastatin | 40 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How BENJAMIN WEISMAN, M.D. fits within the Specialist landscape nationally.
BENJAMIN WEISMAN, M.D.'s 1,631 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as WEISMAN.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is BENJAMIN WEISMAN, M.D.'s specialty? ▼
How much does BENJAMIN WEISMAN, M.D. prescribe under Medicare Part D? ▼
What is BENJAMIN WEISMAN, M.D.'s Medicare quality score? ▼
Where is BENJAMIN WEISMAN, M.D. located? ▼
What is BENJAMIN WEISMAN, M.D.'s NPI number? ▼
How many Specialist providers are there in the US? ▼
What drugs does BENJAMIN WEISMAN, M.D. prescribe most often? ▼
Does BENJAMIN WEISMAN, M.D. accept Medicare? ▼
How can I verify BENJAMIN WEISMAN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology